Virovahl, 1991 - Google Patents
Vahlne et al.Virovahl, 1991
View PDF- Document ID
- 1440562291637019576
- Author
- Virovahl S
- Publication year
- Publication venue
- Dialog
External Links
Snippet
Four peptides corresponding to regions of the glyco protein encoded by the env gene of HTLVl are pro vided. These peptides which are immunologically reac tive with HTLV-l speci? c antibodies are useful in as says for detection of HTLV-l infection or exposure and in …
- 108090000765 processed proteins & peptides 0 abstract description 80
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/531—Production of immunochemical test materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5017687A (en) | Peptides for the detection of HTLV-1 infection | |
US4812556A (en) | Synthetic peptide antigen for the detection of HIV-2 infection | |
CA1340735C (en) | Htlv-iii envelope peptides | |
EP0891982B1 (en) | HIV peptides | |
AU606928B2 (en) | Synthetic peptide antigens for the detection of hiv-1 infection | |
US4879212A (en) | Peptide composition and method for the detection of antibodies to HTLV-III | |
Oldstone et al. | Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy | |
EP0247557B1 (en) | HTLV-III(LAV) Envelope peptides | |
EP0317804B1 (en) | HIV peptides and methods for detection of HIV | |
US4957737A (en) | HTLV-III (LAV) envelope peptides | |
US5582968A (en) | Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis | |
JP2650217B2 (en) | Peptides for diagnosis, treatment and vaccination of HTLV-1 infection | |
CA1339363C (en) | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use | |
JPH03504165A (en) | Synthetic peptide compositions immunoreactive against HTLV-1 antibodies | |
US5283320A (en) | Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom | |
Virovahl | Vahlne et al. | |
CA1338001C (en) | Synthetic peptide antigens for the detection of htlv-1 infection | |
RU1825424C (en) | Method for detecting idv-2 antibodies | |
JPH02500597A (en) | HIV-1 related polypeptides, diagnostic systems and assay methods | |
CA1338028C (en) | Synthetic peptide antigens for the detection of hiv-1 infection | |
JPH0215098A (en) | Synthetic peptide antigen for detecting hiv-1 infection, and its composition and use | |
JPH06503843A (en) | Synthetic peptides corresponding to portions of the HIV-2 virus and methods for their use in improved immunoassays |